|
Status |
Public on Jul 08, 2020 |
Title |
1130_Asc_Top_24hr Rep 2 |
Sample type |
RNA |
|
|
Source name |
MCF-7, ascorbic acid + topotecan, 24 hour, rep 2
|
Organism |
Homo sapiens |
Characteristics |
cells: MCF-7 gender: Female
|
Treatment protocol |
Cell were left untreated or treated with ascorbic acid , topotecan or combinations of ascorbic acid and topotecan for 1 hr and 24 hr.
|
Growth protocol |
MCF-7 breast tumor cells were grown in RPMI 1640 media containing 10% FBS.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted using Triazol method.
|
Label |
Cy3
|
Label protocol |
Starting with 500ng of total RNA, Cy3 labeled cRNA was produced per manufacturer’s protocol.
|
|
|
Hybridization protocol |
For each sample, 1.65ug of Cy3 labeled cRNAs were fragmented and hybridized for 17 hours in a rotating hybridization oven.
|
Scan protocol |
Slides were washed and then scanned with an Agilent Scanner.
|
Description |
Gene expression from MCF-7, ascorbic acid + topotecan, 24 hour
|
Data processing |
Data was obtained using the Agilent Feature Extraction software (v12), using the 1-color defaults for all parameters.
|
|
|
Submission date |
Oct 04, 2019 |
Last update date |
Jul 08, 2020 |
Contact name |
NIEHS Microarray Core |
E-mail(s) |
microarray@niehs.nih.gov, liuliw@niehs.nih.gov
|
Organization name |
NIEHS
|
Department |
DIR
|
Lab |
Microarray Core
|
Street address |
111 T.W. Alexander Drive
|
City |
RTP |
State/province |
NC |
ZIP/Postal code |
27709 |
Country |
USA |
|
|
Platform ID |
GPL4133 |
Series (1) |
GSE138442 |
Effects of ascorbic acid on topotecan-induced DNA damage in human tumor cells |
|